Treatment accepted for restricted use within NHS Scotland.

Avatrombopag is accepted for use within NHS Scotland for severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.

Monitor serum phosphate levels in patients treated with multiple high-dose administrations, or those on long-term treatment, and in those with pre-existing risk factors for hypophosphataemia.